Literature DB >> 12874179

Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury.

Kikuo Isoda1, Masaru Shiigai, Norio Ishigami, Taizo Matsuki, Reiko Horai, Kenichirou Nishikawa, Masatoshi Kusuhara, Yasuhiro Nishida, Yoichiro Iwakura, Fumitaka Ohsuzu.   

Abstract

BACKGROUND: The cytokine interleukin (IL)-1 is an important mediator of inflammation and cardiovascular disease. Activity of this cytokine is modulated endogenously via the IL-1 receptor antagonist (IL-1Ra). The role of IL-1Ra in neointima formation after injury, however, is poorly understood. METHODS AND
RESULTS: Using IL-1Ra-deficient (IL-1Ra-/-; backcrossed 8 generations into the C57BL/6J background) and wild-type (IL-1Ra+/+) mice, we investigated neointimal formation 3 weeks after femoral artery injury induced by an external vascular cuff model. Intima and media thicknesses were measured, and the intima/media ratio was calculated. The mean intimal thickness and the intima/media ratio of IL-1Ra-/- mice increased by 249% (31.8+/-2.9 microm [n=10] versus 9.1+/-0.7 microm [n=10]; P<0.0001) and 257% (2.5+/-0.2 versus 0.7+/-0.1; P<0.0001), respectively, compared with IL-1Ra+/+ mice. No significant differences were observed in the medial thickness. Control immunostaining for IL-1Ra in injured vessels localized IL-1beta and the endogenous inhibitor in the endothelium and inflammatory cells of the adventitia in IL-1Ra+/+ but not IL-1Ra-/- mice.
CONCLUSIONS: The absence of IL-1Ra promotes neointimal formation in mice after injury. These results suggest that endogenous IL-1Ra may suppress other occlusive vascular responses to injury, such as atherosclerosis and restenosis after angioplasty.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874179     DOI: 10.1161/01.CIR.0000085567.18648.21

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  29 in total

Review 1.  Examining the Role of and Treatment Directed at IL-1β in Atherosclerosis.

Authors:  Razi Khan; Eric Rheaume; Jean-Claude Tardif
Journal:  Curr Atheroscler Rep       Date:  2018-09-15       Impact factor: 5.113

2.  Kv1.3 channels modulate human vascular smooth muscle cells proliferation independently of mTOR signaling pathway.

Authors:  Pilar Cidad; Eduardo Miguel-Velado; Christian Ruiz-McDavitt; Esperanza Alonso; Laura Jiménez-Pérez; Agustín Asuaje; Yamila Carmona; Daniel García-Arribas; Javier López; Yngrid Marroquín; Mirella Fernández; Mercè Roqué; M Teresa Pérez-García; José Ramón López-López
Journal:  Pflugers Arch       Date:  2014-09-12       Impact factor: 3.657

3.  Moderate hypoxia potentiates interleukin-1β production in activated human macrophages.

Authors:  Eduardo J Folco; Galina K Sukhova; Thibaut Quillard; Peter Libby
Journal:  Circ Res       Date:  2014-09-02       Impact factor: 17.367

4.  NADPH oxidase 4 is required for interleukin-1β-mediated activation of protein kinase Cδ and downstream activation of c-jun N-terminal kinase signaling in smooth muscle.

Authors:  Roman Ginnan; Frances L Jourd'heuil; Benjamin Guikema; Malorie Simons; Harold A Singer; David Jourd'heuil
Journal:  Free Radic Biol Med       Date:  2012-09-26       Impact factor: 7.376

5.  Inflammatory Response of Pulmonary Artery Smooth Muscle Cells Exposed to Oxidative and Biophysical Stress.

Authors:  Joanna Costa; Yan Zhu; Timothy Cox; Paul Fawcett; Thomas Shaffer; Deepthi Alapati
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

6.  Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice.

Authors:  Janet Chamberlain; David Evans; Andrea King; Rachael Dewberry; Steven Dower; David Crossman; Sheila Francis
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 7.  Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates?

Authors:  Paul M Ridker
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

8.  Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?

Authors:  Paul M Ridker
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

9.  Histone deacetylase-1 is enriched at the platelet-derived growth factor-D promoter in response to interleukin-1beta and forms a cytokine-inducible gene-silencing complex with NF-kappab p65 and interferon regulatory factor-1.

Authors:  Mary Y Liu; Levon M Khachigian
Journal:  J Biol Chem       Date:  2009-10-20       Impact factor: 5.157

Review 10.  The role of IL-1 in the pathogenesis of heart disease.

Authors:  Marcin Bujak; Nikolaos G Frangogiannis
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-05-29       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.